Search
for
Sort by
Research 601–630 of 1000+
- Cosmetic Concerns Among Men
- How to distinguish medicalization from over-medicalization?
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Dermatologie care behind bars
- Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women
- Biotin
- Treatments for alopecia areata: a network meta-analysis
- Titagen® for total wellness: results from a randomised, placebo controlled clinical study on adults for osteoarthritis, improvement in skin, nail and health
- Traditional and Integrative Approaches to the Treatment of Alopecia
- The eyelash follicle features and anomalies: A review
- Scalp Advancement and the Pretrichial Brow Lift
- LncRNA-miRNA-mRNA regulatory networks in skin aging and therapeutic potentials
- New insights into inflammatory memory of epidermal stem cells
- Cue masking and cultural signals: Testing context-specific preferences for bald(ing) leaders
- Inconsolable Crying in Infants: Differential Diagnosis in the Pediatric Emergency Department
- Methods of Using of Cosmeceuticals in Trichological Practice
- Sebum Production
- Development, Characterization of Herbal Emulgel Containing Piper Betle Leaf Extract with In Vivo Studies
- Analysis of Chemical Components in Cosmetics and Their Effects on Human Health and Controversies
- MACROSCOPIC AND MICROSCOPIC LESIONS CHANGE OF DERMATITIS DOG WITH TRIGONA SP HONEY TREATMENT
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- Psychodermatology U.K.
- Contents
- Shiroabhyang - By an Ayurvedic Essential Oils
- Doing Well by Doing Good: The Benevolent Halo of Corporate Social Responsibility
- Revisiting dandruff
- The Use of Platelet-Rich Plasma in Aesthetic and Regenerative Medicine: A Comprehensive Review
- Dissection of genetic variation and evidence for pleiotropy in male pattern baldness
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Lupus panniculitis clinically simulating alopecia areata